Cancer Control Journal Vol 4, No 4
CME Pretest

In this issue, topics addressed include lung cancer and mesothelioma. . First, answer the pretest questions below. After reading the articles, proceed with answering the CME posttest questions.

This Journal provides 4 hours of Category I Continuing Medical Education

Complimentary CME Credits

Physicians can earn up to 4 credit hours of Category I for the Physician's Recognition Award of the American Medical Association by reading the material in this issue and successfully answering the questions on the posttest at the end of this issue. Complete instructions are given on the posttest pages. Every successfully answered 10 questions will earn 1 credit hour. CME is presented by an unrestricted educational grant from Bristol-Myers Oncology Division.

Educational Objectives

After reading this issue, clinicians will be expected to:

• describe the most recent changes in the approach to management of patients with non-small-cell lung cancer,
  
• understand the diagnosis and management of malignant mesotheliomas,
  
• know the safeguards for home transfusion, and
• be aware of patterns of survival in breast cancer relative to the time of first recurrence.

This program was planned in accordance with ACCME Essentials.
Release Date: July 1, 1997 Expiration Date: July 1 , 1998

Pretest

1. Phase II trials of preoperative chemotherapy for localized non-small-cell lung cancer results in complete clearance of tumor in the subsequently resected specimen in what percentage of cases?

a. 0%

b. 15%

c. 30%

d. 45%

2. What is the dose-limiting toxicity of gemcitabine given in a weekly schedule?

a. flu-like syndrome

b. myelosuppression

c. stomatitis

d. edema

3. The five-year survival of patients with diffuse malignant pleural mesothelioma with epithelial histology and negative nodes treated with aggressive trimodal therapy is approximately:

a. 10%

b. 40%

c. 60%

d. 80%